Yale Cancer Center

https://www.yalecancercenter.org/

 

Yale Cancer Center
L

Yale ASH Updates on the Randomized Controlled Phase 3 ALIFE2 Study: Low-Molecular-Weight Heparin for Women With Recurrent Miscarriage and Inherited Thrombophilia

By Yale Cancer Center FEATURING Layla Van Doren
By Yale Cancer Center FEATURING Layla Van Doren
0 views
March 15, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

03:57
Lilly Medical Affairs

Resistance Mechanisms to ET, Including ESR1 Mutations in HR+, HER2- …

Feat. K. Jhaveri

Featured Video

23:35
University of Colorado Division of Hematology

2024 Updates in PV/ET

Feat. B. McMahon
ASH CME Series
14:34
Yale Cancer Center

Yale Cancer Center Allogeneic Stem Cell Transplantation Updates

Feat. L. Bachegowda
14:59
Yale Cancer Center

Advances in CAR-Ts in Myeloma: Recent Research & Clinical Findin…

Feat. N. Bar
16:44
Yale Cancer Center

Summary of Promising Recent Studies in LR-MDS, HR-MDS, and R/R AML

Feat. R. Shallis
34:25
Yale Cancer Center

Splicing Factor Mutations in MDS: Role in Disease Biology and Potent…

Feat. S. Halene
22:16
Yale Cancer Center

Updates on Cellular Therapy Advances in Lymphoma

Feat. I. Isufi
18:19
Yale Cancer Center

Summary of Recent Advances in Adult ALL

Feat. L. Mendez
05:32
Yale Cancer Center

Outcomes of Lovo-Cel Gene Therapy in Sickle Cell Disease: 60-Month F…

Feat. J. Ryu
14:24
Yale Cancer Center

Cancer-Associated VTE: Dynamic Modelling and Prediction With DNA Liq…

Feat. A. Pine
24:12
Yale Cancer Center

Latest Advances in HL and PTCL Treatments

Feat. T. Sethi
14:35
Yale Cancer Center

Case-Based Discussions in Lymphoma: 1L MCL, CD30+ T-Cell, and R/R CLL

Feat. S. Huntington, S. Kothari, T. Sethi
19:56
Yale Cancer Center

Frontline Treatment Strategies in MM: A Comprehensive Overview of Cl…

Feat. T. Parker
12:49
Yale Cancer Center

Emerging Therapies in MF & PV: Insights From Recent Clinical Tri…

Feat. J. Bewersdorf
13:31
Yale Cancer Center

BTKi Rilzabrutinib in Patients With Relapsed ITP

Feat. E. Chang
05:02
Yale Cancer Center

Latest Trial Results for Recombinant ADAMTS13 in cTTP

Feat. J. Ryu
26:25
Yale Cancer Center

Yale Cancer Center Updates on B-Cell Lymphomas: Exploring MCL, DLBCL…

Feat. S. Kothari
33:21
Yale Cancer Center

Review of CAR T-Cell Therapies

Feat. I. Isufi
24:04
Yale Cancer Center

Updates on Allogeneic Stem Cell Transplant

Feat. L. Bachegowda
21:17
Yale Cancer Center

ASH 2022 Highlights: Follicular and Indolent NHL

Feat. F. Montanari
22:32
Yale Cancer Center

Updates From ASH 2022 for LBCL and MCL

Feat. S. Kothari
12:55
Yale Cancer Center

ASH 2022 Highlights: T-Cell Lymphoma and Hodgkin Lymphoma

Feat. T. Sethi
17:49
Yale Cancer Center

Yale ASH Highlights - Myeloid Malignancies: Focus on MPNs

Feat. N. Podoltsev
19:57
Yale Cancer Center

Yale Cancer Center Selected Updates in MDS

Feat. A. Zeidan
11:22
Yale Cancer Center

Yale ASH Highlights: AML Updates

Feat. L. Mendez
07:48
Yale Cancer Center

Yale ASH 2022 Highlights: ALL Updates

Feat. L. Mendez
04:47
Yale Cancer Center

Yale ASH Updates on the Randomized Controlled Phase 3 ALIFE2 Study: …

Feat. L. Van Doren
06:33
Yale Cancer Center

Yale ASH Updates on Sickle Cell Disease: Impact of Hydroxyurea and V…

Feat. L. Van Doren
12:34
Yale Cancer Center

Yale ASH Updates on Classical Hematology: PROs of Sutimlimab Use in …

Feat. G. Goshua
13:17
Yale Cancer Center

Yale ASH Updates on Thrombosis: Apixaban for Central Venous Catheter…

Feat. A. Sharda
25:34
Yale Cancer Center

Newly Diagnosed Myeloma: A Focus on Subgroups at ASH 2022

Feat. N. Bar
27:10
Yale Cancer Center

Highlights in R/R Myeloma and AL Amyloidosis From ASH 2022

Feat. S. Browning